Evaluation of first trimester serum soluble endothelial cell-specific tyrosine kinase receptor in normal and affected pregnancies

References

• Schnurch H, Risau W. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 1993;119:957–68
   PubMed Web of Science ®Google Scholar
• Goldman-Wohl DS, Ariel I, Greenfield C, et al. Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodelling. Mol Hum Reprod 2000;6:81–7
   PubMed Web of Science ®Google Scholar
• Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997;277:48–50
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Kim YM, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005;17:3–18
   PubMed Web of Science ®Google Scholar
• Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21:9–23
   PubMed Web of Science ®Google Scholar
• Espinoza J, Chaiworapongsa T, Romero R, et al. Unexplained fetal death: another anti-angiogenic state. J Matern Fetal Neonatal Med 2007;20:495–507
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Investig 2003;111:649–58
   PubMed Web of Science ®Google Scholar
• Reusch P, Barleon B, Weindel K, et al. Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis 2001;4:123–31
   PubMedGoogle Scholar
• Schneuer FJ, Roberts CL, Ashton AW, et al. Angiopoietin 1 and 2 serum concentrations in first trimester of pregnancy as biomarkers of adverse pregnancy outcomes. Am J Obstet Gynecol 2014;345:e1–e9
   Google Scholar
• Leinonen E, Wathen KA, Alfthan H, et al. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab 2010;95:126–33
   PubMed Web of Science ®Google Scholar
• Gotsch F, Romero R, Kusanovic JP, et al. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. J Matern Fetal Neonatal Med 2008;21:389–402
   PubMed Web of Science ®Google Scholar
• Vuorela P, Matikainen MT, Kuusela P, et al. Endothelial tie receptor antigen in maternal and cord blood of healthy and preeclamptic subjects. Obstet Gynecol 1998;92:179–83
   PubMed Web of Science ®Google Scholar
• Centre for Health Record Linkage. Quality assurance in record linkage. 2009. Available from: http://www.cherel.org.au/CHeReLQualityAssuranceJuly2008.pdf. [last accessed 10 Sep 2013]
   Google Scholar
• Meray N, Reitsma JB, Ravelli AC, Bonsel GJ. Probabilistic record linkage is a valid and transparent tool to combine databases without a patient identification number. J Clin Epidemiol 2007;60:883–91
   PubMed Web of Science ®Google Scholar
• Declercq E, Barger M, Cabral HJ, et al. Maternal outcomes associated with planned primary cesarean births compared with planned vaginal births. Obstet Gynecol 2007;109:669–77
   PubMed Web of Science ®Google Scholar
• Ford JB, Roberts CL, Algert CS, et al. Using hospital discharge data for determining neonatal morbidity and mortality: a validation study. BMC Health Serv Res 2007;7:188
   PubMed Web of Science ®Google Scholar
• Roberts CL, Lancaster PA. Australian national birthweight percentiles by gestational age. Med J Aust 1999;170:114–18
   PubMed Web of Science ®Google Scholar
• Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV
   PubMed Web of Science ®Google Scholar
• Lydon-Rochelle MT, Holt VL, Cardenas V, et al. The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data. Am J Obstet Gynecol 2005;193:125–34
   PubMed Web of Science ®Google Scholar
• Roberts CL, Bell JC, Ford JB, et al. The accuracy of reporting of the hypertensive disorders of pregnancy in population health data. Hypertens Pregnancy 2008;27:285–97
   PubMed Web of Science ®Google Scholar
• Australian Bureau of Statistics. Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA). 2006. Available from: http://www.abs.gov.au/ausstats/[email protected]/mf/2033.0.55.001/. [last accessed 23 Oct 2013]
   Google Scholar
• Schafer JL, Olsen MK. Multiple imputation for multivariate missing-data problems: a data analyst's perspective. Multivar Behav Res 1998;33:545–71
   PubMed Web of Science ®Google Scholar
• New South Wales Government. New South Wales Population Health Survey: Review of weighting procedures. 2006. Available from: http://www.health.nsw.gov.au/pubs/2006/review_weighting.html [last accessed 25 Sep 2012]
   Google Scholar
• Kucharczyk N. Estimation of the lower limit of quantitation, a method detection performance parameter for biomedical assays, from calibration curves. J Chromatogr 1993;612:71–6
   PubMed Web of Science ®Google Scholar
• Lieb W, Zachariah JP, Xanthakis V, et al. Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community. Circ Cardiovasc Genet 2010;3:300–6
   PubMed Web of Science ®Google Scholar
• Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Investig 2007;117:2362–8
   PubMed Web of Science ®Google Scholar
• Molskness TA, Stouffer RL, Burry KA, et al. Circulating levels of total angiopoietin-2 and the soluble Tie-2 receptor in women during ovarian stimulation and early gestation. Fertil Steril 2006;86:1531–3
   PubMed Web of Science ®Google Scholar
• Sung JF, Fan X, Dhal S, et al. Decreased circulating soluble Tie2 levels in preeclampsia may result from inhibition of vascular endothelial growth factor (VEGF) signaling. J Clin Endocrinol Metab 2011;96:E1148–52
   PubMed Web of Science ®Google Scholar
• Findley CM, Cudmore MJ, Ahmed A, Kontos CD. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol 2007;27:2619–26
   PubMed Web of Science ®Google Scholar
• Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004;110:2355–60
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Korzeniewski SJ, et al. Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. J Matern Fetal Neonatal Med 2013;287:e1–e15
   Google Scholar
• Chaiworapongsa T, Romero R, Korzeniewski SJ, et al. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am J Obstet Gynecol 2013;208:287 e1–e15
   PubMed Web of Science ®Google Scholar
• Schneuer FJ, Nassar N, Guilbert C, et al. First trimester screening of serum soluble fms-like tyrosine kinase-1 and placental growth factor predicting hypertensive disorders of pregnancy. Preg Hypertens 2013;3:215–21
   Web of Science ®Google Scholar